Examining the Psychological Burden of Diabetes Mellitus: The Association and Relationship Between Depression, Anxiety, and Diabetes Mellitus. A Systematic Reviewr
DOI:
https://doi.org/10.56570/jimgs.v2i2.109Keywords:
Diabetes Mellitus, Hyperglycaemia, Depression, Anxiety, StressAbstract
Diabetes Mellitus is a global health issue, and the rising prevalence of depression and anxiety among individuals with diabetes poses a significant concern. Metabolic disturbances in diabetes can potentially impact psychological well-being. The study aims to determine the prevalence of depression, and anxiety, and explore the relationship between these mental health conditions and diabetes. A comprehensive search was conducted on PubMed and Google Scholar using MeSH terms and keywords. Articles were selected based on predefined inclusion criteria, and a rigorous quality assessment was performed by two independent authors. Cross-sectional, case-control, systematic reviews, and meta-analysis studies investigating the association between diabetes mellitus, depression, and anxiety were included. After careful quality appraisal, twelve articles were selected for inclusion in the study. These studies were of high quality, some have limitations and a moderate risk of bias. The findings consistently demonstrated a strong association between depression, anxiety, and diabetes mellitus, supported by physiological, biochemical, and anatomical alterations observed in these conditions. The evidence from the included studies supports the coexistence of diabetes, depression, and anxiety. Individuals with diabetes have a higher prevalence of depression and anxiety compared to healthy individuals. All the studies affirm the relationship between diabetes and psychological disorders or disturbance. However, further research is warranted to establish the precise relationship between depression, anxiety, and diabetes and to elucidate the underlying mechanisms through which these mental health conditions may contribute to the development of diabetes mellitus.References
MLA. Harvey, Richard A., Ph. D. Lippincott’s Illustrated Reviews: Biochemistry Philadelphia: Wolters Kluwer Health, 2011.
The International Diabetes Federation https://idf.org/about-diabetes/facts-figures/.
World Health Organization Depression https://www.who.int/news-room/fact- sheets/detail/depression
World Health Organization Mental Disorder https://www.who.int/news-room/fact- sheets/detail/mental-disorders
Liu X, Li Y, Guan L, et al. A Systematic Review and Meta-Analysis of the Prevalence and Risk Factors of Depression in Type 2 Diabetes Patients in China. Front Med. 2022; 9: 759499. Doi: 10.3389/fmed.2022.759499.
Smith KJ, Deschênes SS, Schmitz N. Investigating the longitudinal association between diabetes and anxiety: a systematic review and meta- analysis. Diabet Med. 2018; 35(6): 677-693. Doi: 10.1111/dme.13606.
Ni YX, Ma L, Li JP. Effects of a mindfulness- based intervention on glycemic control and psychological outcomes in people with diabetes: A systematic review and meta-analysis. J Diabet Investig 2021;12(6):1092-1103. Doi: 10.1111/jdi.13439.
Yang W, Liu M, Tian Y, et al. The increased prevalence of depression and anxiety in T2DM patients associated with blood glucose fluctuation and sleep quality. BMC Endocr Disord 2022; 22(1): 232. Doi: 10.1186/s12902-022—1147-8.
Alfieri V, Myasoedova VA, Vinci MC, et al. The Role of Glycemic Variability in Cardiovascular Disorders. Int J Mol Sci 2021; 22(16): 8393. Doi: 10.3390/ijms22168393.
Knight A, Weiss P, Morales K, et al. Identifying Differences in Risk Factors for Depression and Anxiety in Pediatric Chronic Disease: A Matched Cross-Sectional Study of Youth with Lupus/Mixed Connective Tissue Disease and Their Peers with Diabetes. J Pediatr 2015; 167(6): 1397-403.e1. Doi: 10.1016/j.jpeds.2015.07.048.
Dogan B, Oner C, Akalin AA, et al. Psychiatric symptom rate of patients with Diabetes Mellitus: A case control study. Diabetes Metab Syndr 2019; 13(2): 1059-1063. Doi: 10.1016/j.dsx.2019.01.045.
Zhou C, Li J, Dong M, et al. Altered White Matter Microstructures in Type 2 Diabetes Mellitus: A Coordinate‐Based Meta‐Analysis of Diffusion Tensor Imaging Studies. Front in Endocrinol (Lausanne) 2021; 12: 658198. Doi: 10.3389/fendo.2021.65819.
Yang QQ, Shao D, Li J, et al. Positive Association Between Serum Levels of High-Sensitivity C-Reactive Protein and Depression/Anxiety in Female, but Not Male, Patients With Type 2 Diabetes Mellitus. Biol Res Nurs 2020; 22(2): 178-187. Doi: 10.1177/109980041989464.
Page MJ, McKenzie JE, Bossuyt PM, et al.: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: 10.1136/BMJ.N71.
Rechenberg K, Koerner R. Cognitive Behavioral Therapy in Adolescents with Type 1 Diabetes: An Integratve Review. J Pediatr Nurs 2021; 60: 190-197. Doi: 10.1016/j.pedn.2021.06.019.
Graham EA, Deschênesc SS, Khalil MN, et al. Measures of depression and risk of type 2 diabetes: A systematic review and meta-analysis. J Affective Disorders 2020; 224-232. Doi: 10.1016/j.jad.2020.01.053.
Almeida MC, Claudino DA, Grigolon RB, et al. Psychiatric disorders in adolescents with type 1 diabetes: a case-control study. Braz J Psychiatry. 2018; 40(3): 284-289. Doi:10.1590/1516-4446-2017-2259.
18 Berger G, Waldhoer T, Barrientos I, et al. Association of insulin-manipulation and psychiatric disorders: A systematic epidemiological evaluation of adolescents with type 1 diabetes in Austria. Pediatr Diabetes 2019; 20(1): 127-136. Doi: 10.1111/pedi.12784.
Nguyen LA, Pouwer F, Winterdijk P, et al. Prevalence and course of mood and anxiety disorders, and correlates of symptom severity in adolescents with type 1 diabetes: Results from diabetes LEAP J pedi 2020. Doi: 10.1111/pedi.13174.
Liu J, Liu T, Wang W, et al. Reduced Gray Matter Volume in Patients with Type 2 Diabetes Mellitus. Front Aging Neurosci. 2017; 9:161. Doi: 10.3389/fnagi.2017.00161.
Pouwer F, Snoek FJ. The association between symptoms of depression and glycaemic control may be unstable across gender. Diabet Med 2001; 18(7): 595- 8. doi: 10.1046/j.1464-5491.2001.00499.x.
Holmes-Truscott E, Browne JL, Speight J. The impact of insulin therapy and attitudes towards insulin intensification among adults with type 2 diabetes: A qualitative study. J Diabetes Complication 2016; 30(6): 1151-7. Doi: 10.1016/j.jdiacomp.2016.03.027.
Grylli V, Hafferl-Gattermayer A, Schober E, Karwautz A. Prevalence and clinical manifestations of eating disorders in Austrian adolescents with type-1 diabetes. Wien Klin Wochenschr 2004; 116(7-8): 230- 234.
Diagnostic and Statistical Manual of Mental Disorders. Washington, DC American Psychiatric Association; 2013.
Schober E, Wagner G, Berger G, et al; Austrian Diabetic Incidence Study Group. Prevalence of intentional under- and overdosing of insulin in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2011; 12(7): 627-31. Doi: 10.1111/j.1399- 5448.2011.00759. x.
Bell B, Lin JJ, Seidenberg M, Hermann B. The Neurobiology of Cognitive Disorders in Temporal Lobe Epilepsy. Nat Rev Neurol 2011; 7(3): 154–64. Doi: 10.1038/nrneurol.2011.3.
Wikenheiser AM, Schoenbaum G. Over the River, Through the Woods: Cognitive Maps in the Hippocampus and Orbitofrontal Cortex. Nat Rev Neurosci 2016; 17(8): 513–23. doi: 10.1038/nrn.2016.56.
Repple J, Opel N, Meinert S, et al. Elevated Body-Mass Index is Associated With Reduced White Matter Integrity in Two Large Independent Cohorts. Psychoneuroendocrinology 2018; 91: 179–85. Doi: 10.1016/j.psyneuen.2018.03.007.
Swan GE, Carmelli D. Impaired Olfaction Predicts Cognitive Decline in Nondemented Older Adults. Neuroepidemiology 2002; 21(2): 58–67. Doi: 10.1038/s41582-018-0097-5.
Murphy C. Olfactory and Other Sensory Impairments in Alzheimer Disease. Nat Rev Neurol 2019; 15(1): 11–24. Doi: 10.1038/s41582-018-0097- 5.
Alfaro FJ, Gavrieli A, Saade-Lemus P, et al. White Matter Microstructure and Cognitive Decline in Metabolic Syndrome: A Review of Diffusion Tensor Imaging. Metabol: Clin Exp 2018; 78:52–68. Doi: 10.1016/j.metabol.2017.08.009.
Culpepper L. Generalized anxiety disorder and medical illness. J Clin Psychiatry 2009; 70(2): 20–24.
Campayo, A., de Jonge, P., Roy, J.F.,et al. Depressive disorder and incident diabetes mellitus: the effect of characteristics of depression. Am. J Psychiatry 2010 ;167, 580–588. Doi: 10.1176/appi.ajp.2009.09010038.
Mezuk B, Chaikiat Å, Li X, et al. Depression, neighborhood deprivation and risk of type 2 diabetes. Health Place 2013; 23: 63-9
Golden SH, Lazo M, Carnethon M, et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA 2008; 299(23): 2751-9. Doi: 10.1001/jama.299.23.2751.
Khaledi M, Haghighatdoost F, Feizi A, Aminorroaya A. The Prevalence of Comorbid Depression in Patients with Type 2 Diabetes: an updated systematic review and Meta-analysis on a huge Number of observational studies. Acta Diabetol 2019; 56: 631–50. Doi: 10.1007/s00592-019-01295-9.
Fuchs M, Bosch A, Hausmann A, Steiner H. Review of literature on epidemiology in child and adolescent psychiatry. Z Kinder Jugendpsychiatr Psychother 2013; 41: 45-55. Doi: 10.1024/1422- 4917/a000209.
Philipp J, Zeiler M, Waldherr K, Nitsch M, Dur W, Karwautz A, et al. The Mental Health in Austrian Teenagers (MHAT)-Study: preliminary results from a pilot study. Neuropsychiatr 2014; 28: 198-207. Doi: 10.1007/s40211-014-0131-9.
Fuchs M, Bosch A, Hausmann A, Steiner H. Review of literature on epidemiology in child and adolescent psychiatry. Z Kinder Jugendpsychiatr Psychother 2013; 41: 45-55. Doi: 10.1024/1422- 4917/a000209.
David D, Cristea, I, Hofmann, S. G. Why cognitive behavioral therapy is the current gold standard of psychotherapy. Front Psychiatry 2018; 9, 4. Doi: 10.3389/fpsyt.2018.00004.
Edmunds JM, Brodman DM, Ringle VA, et al. Examining adherence to components of cognitive- behavioral therapy for youth anxiety after training and consultation. Prof Psychol Res Pr 2017; 48(1), 54. Doi: 10.1037/PRO0000100.
Hans E, & Hiller W. A meta-analysis of nonrandomized effectiveness studies on outpatient cognitive behavioral therapy for adult anxiety disorders. Clin Psychol Rev 2013; 33(8): 954–964. Doi: 10.1016/j.cpr.2013.07.003.
Kaczkurkin AN, Foa EB. Cognitive-behavioral therapy for anxiety disorders: An update on the empirical evidence. Dialogues Clin Neurosci 2015; 17(3): 337. Doi: 10.31887/DCNS.2015.17.3/akaczkurkin.
Watts SE, Turnell A, Kladnitsk N, et al. Treatment-as-usual (TAU) is anything but usual: A meta-analysis of CBT versus TAU for anxiety and depression. J Affect Disord 2015; 175152: 167. Doi: 10.1016/j.jad.2014.12.025.
Weitz ES, Hollon SD, Twisk J, et al. Baseline depression severity as moderator of depression outcomes between cognitive behavioral therapy vs pharmacotherapy: An individual patient data meta- analysis. JAMA Psychiatry 2015; 72(11): 1102. Doi:10.1001/jamapsychiatry.2015.1516.
Carlbring P, Andersson G., Cuijpers, P, et al. Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: An updated systematic review and meta-analysis. Cogn Behav Ther. 2018; 47(1): 1–18. Doi: 10.1080/16506073.2017.1401115.
Wagner B, Horn AB, Maercker A. Internet- based versus face-to-face cognitive-behavioral intervention for depression: A randomized controlled non-inferiority trial. J Affect Disord 2014; 152: 113– 121. doi: 10.1016/j.jad.2013.06.032.
Wang Z, Whiteside SP, Sim L, et al. Comparative effectiveness and safety of cognitive behavioral therapy and pharmacotherapy for childhood anxiety disorders: A systematic review and meta- analysis. JAMA Pediatr 2017; 171(11): 1049–1056. Doi:10.1001/jamapediatrics.2017.3036.
